Viridian Therapeutics Inc (VRDN)

NASDAQ · Biotechnology

18.66
+0.32 (+1.74%)
Updated Oct 9, 11:00 PM ET
AI Rating
Strong Sell
Overall Score
23
Trend
3
Momentum
20
Risk
58

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Sep 24, 2025 260 sessions Oct 6, 2026

AI Analysis

Viridian Therapeutics Inc is trading at $18.66, up 1.74% on the session. The 50 day average sits at $21.92 and the 200 day at $22.69, which puts the stock in a downtrend. RSI is at 30.5, which reads as weak, and MACD is bearish crossover. Volume is above average.

The nearest support is around $17.54 with resistance near $20.10, so that band frames the current range. Average daily movement is roughly $0.92, or about 4.9% of the share price, which is what any stop placement has to allow for. The overall health score of 23 out of 100 combines a trend score of 3, momentum of 20 and a risk score of 58.

Technical indicators

RSI (14)
30.5
weak
MACD
-0.899
bearish crossover
SMA 20
20.98
SMA 50
21.92
SMA 200
22.69
downtrend
ATR (14)
0.92
avg daily range
Support
17.54
Resistance
20.10
Volume vs 20d
1.14x
above average
Volatility
48.9%
annualised
1 month
-20.51%
3 months
-8.26%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.